Latanostad Comp

Latanoprost/timolol, the active ingredient in Latanostad Comp, is a prostaglandin analog and non‑selective beta‑blocker combination presented as an ophthalmic solution for ocular (topical) use. It treats open‑angle glaucoma and ocular hypertension in adult patients by lowering intra‑ocular pressure.

GNH USA supplies Latanostad Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution across EU and other global markets. The company ensures quality compliance and reliable logistics for its clients.

Latanostad Comp, a prostaglandin analog and beta‑blocker eye drop, is indicated for conditions that require reduction of intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic nerve damage. Ocular hypertension: lowers eye pressure to reduce risk of developing glaucoma. Secondary open‑angle glaucoma: assists in controlling pressure when caused by other ocular conditions. Pseudoexfoliation glaucoma: helps manage elevated pressure.

Latanostad Comp may cause ocular and systemic adverse reactions; they are categorized by frequency and severity.

Common Side Effects: - Eye irritation or burning sensation - Blurred vision shortly after instillation - Redness of the conjunctiva - Increased eyelash growth - Darkening of the iris color

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angioedema) - Ocular inflammation or uveitis - Marked reduction in heart rate (bradycardia) - Bronchospasm in susceptible individuals - Systemic hypotension leading to dizziness

Before prescribing Latanostad Comp, clinicians should consider several precautionary measures to ensure patient safety. - Monitor intra‑ocular pressure: assess baseline and follow‑up measurements after initiation. - Assess cardiovascular status: timolol may cause bradycardia or affect blood pressure. - Avoid in patients with asthma or COPD: beta‑blockade can precipitate bronchospasm. - Use caution in severe ocular surface disease: may exacerbate irritation. - Pregnancy and lactation: safety not established; weigh potential risks against benefits. - Store at room temperature: keep in original container, protect from light and moisture.

Latanostad Comp can interact with other medications, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Non‑selective beta‑blocker antagonists (e.g., propranolol): additive bradycardia. - Systemic beta‑agonists (e.g., albuterol): reduced bronchodilator effect. - Other prostaglandin analog eye drops: increased risk of ocular side effects.

Moderate Interactions (Monitor Closely): - Carbonic anhydrase inhibitor eye drops: additive intra‑ocular pressure lowering effect. - Alpha‑agonist ocular drops (e.g., apraclonidine): possible additive hypotensive effect. - Systemic antihypertensives: monitor blood pressure for excessive lowering.